For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 7 to 11 in Orlando, ...
Mar 19, 2025
0
0
Small amounts of a common antibiotic and anti-inflammatory drug can curb symptoms where a misplaced immune reaction (e.g., autoimmunity) can cause permanent hair loss, a new study shows. This regimen may also come with fewer ...
Mar 18, 2025
0
27
The Hass Avocado Board teamed up with the University of Eastern Finland researchers to examine the relationship between maternal avocado consumption during pregnancy and allergic outcomes in infants. Findings suggest that ...
In a recent, cross-institutional study, researchers report that healthy human airways are at higher risk for dehydration and inflammation when exposed to dry air, an occurrence expected to increase due to global warming. ...
Mar 17, 2025
0
22
Why do medications that are supposed to help patients with chronic inflammatory diseases sometimes lead to blood clots?
Mar 17, 2025
0
0
Janus kinase (JAK) inhibitors are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis. Since their approval, the indications ...
Mar 17, 2025
0
0
In one of the first studies of its kind, a team of researchers from Keck School of Medicine of USC has found that proteins and pathways involved in inflammation are associated with changes in bone mineral density (BMD) over ...
Mar 14, 2025
0
2
Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid withdrawal (TSW) is distinct from eczema and is caused by an excess of an essential chemical compound in ...
Mar 14, 2025
0
1
Once-daily roflumilast cream 0.05% is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according to a study published online Feb. 20 in Pediatric Dermatology.
Mar 14, 2025
0
0
Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease activity after about 80 days off treatment, according to a study presented at the annual meeting of ...
Mar 14, 2025
0
0
